Home›People›Justin Kao
JK

Justin Kao

Director at Inflammatix.

Director
Updated Nov 2, 2026·Latest SEC filing Mar 24, 2021·Suggest an edit

About Justin Kao

Form D filings for Inflammatix in 2021 list Justin Kao as director.

Justin Kao first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Justin Kao in the role, so the role may have started earlier or lasted longer.

Inflammatix, Inc.
Director
2021 · Sunnyvale, CA
Inflammatix helps emergency teams identify infection type and illness severity from the body's immune response.

Key Colleagues at Startups

The people Justin Kao works with at each company, as listed on that company's latest Form D.

Inflammatix, Inc. · Form D, Mar 24, 2021
MR
KB
Kenneth Bahk
Director
Timothy Sweeney
Timothy Sweeney
Co-Founder and CEO, director
Steven Tablak
Steven Tablak
Former Chairman and CEO, GeneWeave
David Persing
David Persing
EVP/Chief Medical Officer, Cepheid and director

Sources

  1. SECInflammatix, Inc. Form D, filed Mar 24, 2021